(CSR) Centerspace - Ratings and Ratios
Apartment Communities, Rental Homes, Multifamily Properties, Residential Leasing
CSR EPS (Earnings per Share)
CSR Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.6% |
| Value at Risk 5%th | 42.5% |
| Relative Tail Risk | -6.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -13.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.552 |
| Beta | 0.456 |
| Beta Downside | 0.537 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.08% |
| Mean DD | 12.42% |
| Median DD | 13.49% |
Description: CSR Centerspace November 16, 2025
Centerspace (NYSE:CSR) is a U.S. multifamily REIT that owns and operates 72 apartment communities comprising 13,353 units across the Mountain-West and Upper Midwest as of June 30 2025. The company emphasizes “integrity” and “service” in its tenant-focused strategy and has been recognized as a top workplace by the Minneapolis Star Tribune for six straight years.
Key market drivers that could affect CSR’s performance include: (1) regional rent growth of roughly 4.2% YoY in the eight states where it operates, driven by limited new supply and strong in-migration; (2) an average occupancy rate of about 95%, which is above the national multifamily average of 92% and suggests pricing power; and (3) a prevailing cap-rate environment of 5.5%–6.0% for similar-size assets, reflecting moderate investor appetite amid a still-elevated Federal Funds Rate. These metrics are subject to change if macro-economic conditions-particularly employment trends and interest-rate policy-shift significantly.
If you want a data-rich, independent assessment of CSR’s fundamentals, consider reviewing ValueRay’s detailed analytics on rent growth, occupancy trends, and comparable cap-rate benchmarks.
CSR Stock Overview
| Market Cap in USD | 1,057m |
| Sub-Industry | Multi-Family Residential REITs |
| IPO / Inception | 1997-10-17 |
| Return 12m vs S&P 500 | -16.2% |
| Analyst Rating | 3.67 of 5 |
CSR Dividends
| Dividend Yield | 4.58% |
| Yield on Cost 5y | 5.10% |
| Yield CAGR 5y | 1.74% |
| Payout Consistency | 94.3% |
| Payout Ratio | 169.1% |
CSR Growth Ratios
| CAGR 3y | 5.13% |
| CAGR/Max DD Calmar Ratio | 0.17 |
| CAGR/Mean DD Pain Ratio | 0.41 |
| Current Volume | 366.1k |
| Average Volume | 110.6k |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (-21.6m TTM) > 0 and > 6% of Revenue (6% = 16.4m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -186.2% (prev -124.5%; Δ -61.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 104.4m > Net Income -21.6m (YES >=105%, WARN >=100%) |
| Net Debt (509.2m) to EBITDA (194.0m) ratio: 2.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (19.8m) change vs 12m ago 27.32% (target <= -2.0% for YES) |
| Gross Margin 65.66% (prev 26.16%; Δ 39.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.72% (prev 13.67%; Δ 0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.90 (EBITDA TTM 194.0m / Interest Expense TTM 43.1m) >= 6 (WARN >= 3) |
Altman Z'' -1.63
| (A) -0.24 = (Total Current Assets 12.9m - Total Current Liabilities 522.1m) / Total Assets 2.10b |
| (B) -0.29 = Retained Earnings (Balance) -618.3m / Total Assets 2.10b |
| (C) 0.04 = EBIT TTM 81.8m / Avg Total Assets 1.99b |
| (D) 0.62 = Book Value of Equity 748.6m / Total Liabilities 1.21b |
| Total Rating: -1.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.86
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 6.67% = 3.33 |
| 3. FCF Margin 38.18% = 7.50 |
| 4. Debt/Equity 0.70 = 2.26 |
| 5. Debt/Ebitda 2.62 = -1.18 |
| 6. ROIC - WACC (= -0.05)% = -0.07 |
| 7. RoE -3.11% = -0.52 |
| 8. Rev. Trend 41.25% = 3.09 |
| 9. EPS Trend -51.38% = -2.57 |
What is the price of CSR shares?
Over the past week, the price has changed by +13.84%, over one month by +10.33%, over three months by +22.77% and over the past year by -3.07%.
Is Centerspace a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSR is around 68.89 USD . This means that CSR is currently overvalued and has a potential downside of 3.02%.
Is CSR a buy, sell or hold?
- Strong Buy: 2
- Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CSR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.9 | 0% |
| Analysts Target Price | 66.9 | 0% |
| ValueRay Target Price | 75.2 | 12.5% |
CSR Fundamental Data Overview November 10, 2025
P/E Trailing = 33.0497
P/E Forward = 55.5556
P/S = 3.8647
P/B = 1.3869
Beta = 0.806
Revenue TTM = 273.4m USD
EBIT TTM = 81.8m USD
EBITDA TTM = 194.0m USD
Long Term Debt = 908.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 522.1m USD (from shortTermDebt, last quarter)
Debt = 522.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 509.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.57b USD (1.06b + Debt 522.1m - CCE 12.9m)
Interest Coverage Ratio = 1.90 (Ebit TTM 81.8m / Interest Expense TTM 43.1m)
FCF Yield = 6.67% (FCF TTM 104.4m / Enterprise Value 1.57b)
FCF Margin = 38.18% (FCF TTM 104.4m / Revenue TTM 273.4m)
Net Margin = -7.91% (Net Income TTM -21.6m / Revenue TTM 273.4m)
Gross Margin = 65.66% ((Revenue TTM 273.4m - Cost of Revenue TTM 93.9m) / Revenue TTM)
Gross Margin QoQ = 89.96% (prev 57.81%)
Tobins Q-Ratio = 0.75 (Enterprise Value 1.57b / Total Assets 2.10b)
Interest Expense / Debt = 2.49% (Interest Expense 13.0m / Debt 522.1m)
Taxrate = -25.28% (negative due to tax credits) (2.86m / -11.3m)
NOPAT = 102.5m (EBIT 81.8m * (1 - -25.28%)) [negative tax rate / tax credits]
Current Ratio = 0.02 (Total Current Assets 12.9m / Total Current Liabilities 522.1m)
Debt / Equity = 0.70 (Debt 522.1m / totalStockholderEquity, last quarter 748.6m)
Debt / EBITDA = 2.62 (Net Debt 509.2m / EBITDA 194.0m)
Debt / FCF = 4.88 (Net Debt 509.2m / FCF TTM 104.4m)
Total Stockholder Equity = 695.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.03% (Net Income -21.6m / Total Assets 2.10b)
RoE = -3.11% (Net Income TTM -21.6m / Total Stockholder Equity 695.6m)
RoCE = 5.10% (EBIT 81.8m / Capital Employed (Equity 695.6m + L.T.Debt 908.0m))
RoIC = 6.12% (NOPAT 102.5m / Invested Capital 1.67b)
WACC = 6.18% (E(1.06b)/V(1.58b) * Re(7.69%) + D(522.1m)/V(1.58b) * Rd(2.49%) * (1-Tc(-0.25)))
Discount Rate = 7.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 14.76%
[DCF Debug] Terminal Value 76.53% ; FCFE base≈91.6m ; Y1≈81.8m ; Y5≈69.3m
Fair Price DCF = 75.12 (DCF Value 1.25b / Shares Outstanding 16.7m; 5y FCF grow -13.13% → 3.0% )
EPS Correlation: -51.38 | EPS CAGR: -64.27% | SUE: -3.15 | # QB: 0
Revenue Correlation: 41.25 | Revenue CAGR: 1.87% | SUE: 2.95 | # QB: 1
Additional Sources for CSR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle